(Q44293552)

1 December 2017

title

Gabapentin-induced paradoxical exacerbation of psychosis in a patient with schizophrenia (English)

1 reference

1 December 2017

0 references

0 references

1 reference

Karin Jablonowski

1

1 reference

1 December 2017

Howard C Margolese

series ordinal

2

1 reference

1 December 2017

Guy Chouinard

series ordinal

3

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Canadian Journal of Psychiatry

1 December 2017

published in

1 reference

1 December 2017

volume

47

1 reference

1 December 2017

issue

10

1 reference

1 December 2017

page(s)

975-976

1 reference

Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674370204701017

Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204701017

Placebo-controlled study of gabapentin treatment of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204701017

Gabapentin-associated aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204701017

Gabapentin-induced mood changes with hypomanic features in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204701017

Clozapine for first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370204701017

10.1177/070674370204701017

21 January 2018

Identifiers

DOI

0 references

1 reference